Home
>
National Drug Code (NDC)
>
Fenofibrate
Fenofibrate - 0093-2061-98 - (Fenofibrate)
Drug Information of Fenofibrate
| Product NDC: | 0093-2061 |
| Proprietary Name: | Fenofibrate |
| Non Proprietary Name: | Fenofibrate |
| Active Ingredient(s): | 48 mg/1 & nbsp; Fenofibrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Fenofibrate
| Product NDC: | 0093-2061 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021656 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20041105 |
Package Information of Fenofibrate
| Package NDC: | 0093-2061-98 |
| Package Description: | 90 TABLET in 1 BOTTLE (0093-2061-98) |
NDC Information of Fenofibrate
| NDC Code | 0093-2061-98 |
| Proprietary Name | Fenofibrate |
| Package Description | 90 TABLET in 1 BOTTLE (0093-2061-98) |
| Product NDC | 0093-2061 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fenofibrate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20041105 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | FENOFIBRATE |
| Strength Number | 48 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [Chemical/Ingredient] |
